APA (7th ed.) Citation

Speicher, T., Latell, S., Blickle, A., Bastian, M. B., Maus, S., Schaefer-Schuler, A., . . . Rosar, F. (2026). Zirconium-89-based PSMA PET/CT with delayed imaging for early detection of biochemical recurrence in prostate cancer patients with PSA ≤ 0.2 ng/mL: A feasibility study. European Journal of Nuclear Medicine & Molecular Imaging, 53(9), 5408. https://doi.org/10.1007/s00259-026-07854-x

Chicago Style (17th ed.) Citation

Speicher, Tilman, et al. "Zirconium-89-based PSMA PET/CT with Delayed Imaging for Early Detection of Biochemical Recurrence in Prostate Cancer Patients with PSA ≤ 0.2 Ng/mL: A Feasibility Study." European Journal of Nuclear Medicine & Molecular Imaging 53, no. 9 (2026): 5408. https://doi.org/10.1007/s00259-026-07854-x.

MLA (9th ed.) Citation

Speicher, Tilman, et al. "Zirconium-89-based PSMA PET/CT with Delayed Imaging for Early Detection of Biochemical Recurrence in Prostate Cancer Patients with PSA ≤ 0.2 Ng/mL: A Feasibility Study." European Journal of Nuclear Medicine & Molecular Imaging, vol. 53, no. 9, 2026, p. 5408, https://doi.org/10.1007/s00259-026-07854-x.